igen biotech is a privately-held biotechnological company which translates biomedical research into practical and marketable medical devices and/or services that contribute to human health improvement. As a technology-based company, igen biotech focuses its activity on research and development of innovative products and/or services for genetic diagnosis of cancer and inflammatory diseases, among other, cooperating to this aim with outstanding biomedical research centers in Europe. Our current product portfolio includes an advanced DNA extraction technology (CE-IVD) specifically designed for low cellularity samples, such as prenatal samples, among other: blood, circulating cell-free DNA and formalin-fixed paraffin embedded tissue. igen biotech's products are manufactured and commercialized worldwide through our spin-off ilab tech: https://www.ilabtech.es .